These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27812215)

  • 41. Endoplasmic reticulum stress intolerance in EIF2B3 mutant oligodendrocytes is modulated by depressed autophagy.
    Chen N; Dai L; Jiang Y; Wang J; Hao H; Ren Y; Leng X; Zang L; Wu Y
    Brain Dev; 2016 May; 38(5):507-15. PubMed ID: 26625702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. eIF2B-catalyzed nucleotide exchange and phosphoregulation by the integrated stress response.
    Kenner LR; Anand AA; Nguyen HC; Myasnikov AG; Klose CJ; McGeever LA; Tsai JC; Miller-Vedam LE; Walter P; Frost A
    Science; 2019 May; 364(6439):491-495. PubMed ID: 31048491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes.
    Wong YL; LeBon L; Edalji R; Lim HB; Sun C; Sidrauski C
    Elife; 2018 Feb; 7():. PubMed ID: 29489452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of vanishing white matter disease in mice.
    Lin Y; Pang X; Huang G; Jamison S; Fang J; Harding HP; Ron D; Lin W
    J Neurosci; 2014 Sep; 34(36):12182-91. PubMed ID: 25186761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.
    Horzinski L; Huyghe A; Cardoso MC; Gonthier C; Ouchchane L; Schiffmann R; Blanc P; Boespflug-Tanguy O; Fogli A
    PLoS One; 2009 Dec; 4(12):e8318. PubMed ID: 20016818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease.
    Raini G; Sharet R; Herrero M; Atzmon A; Shenoy A; Geiger T; Elroy-Stein O
    J Neurochem; 2017 Jun; 141(5):694-707. PubMed ID: 28306143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutational analysis of the alpha subunit of eIF2B provides insights into the role of eIF2B bodies in translational control and VWM disease.
    Norris K; Hodgson RE; Dornelles T; Allen KE; Abell BM; Ashe MP; Campbell SG
    J Biol Chem; 2021; 296():100207. PubMed ID: 33334879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human-induced pluripotent stem cell-derived cerebral organoid of leukoencephalopathy with vanishing white matter.
    Deng J; Zhang J; Gao K; Zhou L; Jiang Y; Wang J; Wu Y
    CNS Neurosci Ther; 2023 Apr; 29(4):1049-1066. PubMed ID: 36650674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viral evasion of the integrated stress response through antagonism of eIF2-P binding to eIF2B.
    Schoof M; Wang L; Cogan JZ; Lawrence RE; Boone M; Wuerth JD; Frost A; Walter P
    Nat Commun; 2021 Dec; 12(1):7103. PubMed ID: 34876554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surviving and Adapting to Stress: Translational Control and the Integrated Stress Response.
    Wek RC; Anthony TG; Staschke KA
    Antioxid Redox Signal; 2023 Aug; 39(4-6):351-373. PubMed ID: 36943285
    [No Abstract]   [Full Text] [Related]  

  • 51. In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice.
    Böck D; Revers IM; Bomhof ASJ; Hillen AEJ; Boeijink C; Kissling L; Egli S; Moreno-Mateos MA; van der Knaap MS; van Til NP; Schwank G
    Mol Ther; 2024 May; 32(5):1328-1343. PubMed ID: 38454603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A point mutation in translation initiation factor 2B leads to a continuous hyper stress state in oligodendroglial-derived cells.
    Kantor L; Pinchasi D; Mintz M; Hathout Y; Vanderver A; Elroy-Stein O
    PLoS One; 2008; 3(11):e3783. PubMed ID: 19023445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leukoencephalopathy with vanishing white matter: a review.
    Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS
    J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of protein synthesis in lymphoblasts from vanishing white matter patients.
    van Kollenburg B; Thomas AA; Vermeulen G; Bertrand GA; van Berkel CG; Pronk JC; Proud CG; van der Knaap MS; Scheper GC
    Neurobiol Dis; 2006 Mar; 21(3):496-504. PubMed ID: 16185887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lithium: effects in animal models of vanishing white matter are not promising.
    Witkamp D; Oudejans E; Hoogterp L; Hu-A-Ng GV; Glaittli KA; Stevenson TJ; Huijsmans M; Abbink TEM; van der Knaap MS; Bonkowsky JL
    Front Neurosci; 2024; 18():1275744. PubMed ID: 38352041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protection of eIF2B from inhibitory phosphorylated eIF2: A viral strategy to maintain mRNA translation during the PKR-triggered integrated stress response.
    Ito T; Wuerth JD; Weber F
    J Biol Chem; 2023 Nov; 299(11):105287. PubMed ID: 37742919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional analysis of recently identified mutations in eukaryotic translation initiation factor 2Bɛ (eIF2Bɛ) identified in Chinese patients with vanishing white matter disease.
    Leng X; Wu Y; Wang X; Pan Y; Wang J; Li J; Du L; Dai L; Wu X; Proud CG; Jiang Y
    J Hum Genet; 2011 Apr; 56(4):300-5. PubMed ID: 21307862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B.
    Sudhakar A; Ramachandran A; Ghosh S; Hasnain SE; Kaufman RJ; Ramaiah KV
    Biochemistry; 2000 Oct; 39(42):12929-38. PubMed ID: 11041858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].
    Labauge P; Fogli A; Niel F; Rodriguez D; Boespflug-Tanguy O
    Rev Neurol (Paris); 2007 Sep; 163(8-9):793-9. PubMed ID: 17878805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exon deletion in the non-catalytic domain of eIF2Bepsilon due to a splice site mutation leads to infantile forms of CACH/VWM with severe decrease of eIF2B GEF activity.
    Horzinski L; Gonthier C; Rodriguez D; Scherer C; Boespflug-Tanguy O; Fogli A
    Ann Hum Genet; 2008 May; 72(Pt 3):410-5. PubMed ID: 18294360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.